MedTrace Logo

Salivary IgA and Cytokines Response to Dietary Supplementation of Lactobacillus Reuteri

NCT02017886 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2016-05-11

No results posted yet for this study

Summary

To evaluate the effect of daily ingestion of the probiotic Lactobacillus reuteri on the levels of secretory IgA and the cytokines Il1-beta, IL-6, IL-8 and IL-10 in saliva of healthy young adults.

Conditions

  • Dental Caries
  • Periodontitis

Interventions

DIETARY_SUPPLEMENT

L. reuteri DSM 17938/ATCC PTA

L. reuteri DSM 17938/ATCC PTA twice daily for three weeks

DIETARY_SUPPLEMENT

Placebo

Placebo tablet twice daily for three weeks

Sponsors & Collaborators

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Mette Rose Jørgensen, PhD-student · University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2015-12-31
Completion
2016-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02017886 on ClinicalTrials.gov